Trial Outcomes & Findings for Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels (NCT NCT00441480)

NCT ID: NCT00441480

Last Updated: 2012-01-13

Results Overview

Average of blood test results at -10 and 0 days (before and after run-in period)

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

91 participants

Primary outcome timeframe

at baseline

Results posted on

2012-01-13

Participant Flow

Recruitment period:r May 2007-Jan 2008 (8 months) Medical center

10 -14 days run-in phase during which they received placebo capsules. Run-in phase enabled to exclude subjects who had an unstable weight (gained or lost more than 3 kg) during this period or who didn't meet entry criteria of LDL-c and TG at screening visit and at baseline visit.

Participant milestones

Participant milestones
Measure
PS-FO
plant sterols esterified to fish oil fatty acids
Control
Corn oil
Overall Study
STARTED
46
45
Overall Study
COMPLETED
43
41
Overall Study
NOT COMPLETED
3
4

Reasons for withdrawal

Reasons for withdrawal
Measure
PS-FO
plant sterols esterified to fish oil fatty acids
Control
Corn oil
Overall Study
Protocol Violation
1
1
Overall Study
Withdrawal by Subject
2
3

Baseline Characteristics

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
PS-FO
n=46 Participants
plant sterols esterified to fish oil fatty acids
Control
n=45 Participants
Corn oil
Total
n=91 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
41 Participants
n=5 Participants
43 Participants
n=7 Participants
84 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
2 Participants
n=7 Participants
7 Participants
n=5 Participants
Age Continuous
51 years
STANDARD_DEVIATION 10.8 • n=5 Participants
49.4 years
STANDARD_DEVIATION 9.3 • n=7 Participants
50.2 years
STANDARD_DEVIATION 10.1 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
11 Participants
n=7 Participants
20 Participants
n=5 Participants
Sex: Female, Male
Male
37 Participants
n=5 Participants
34 Participants
n=7 Participants
71 Participants
n=5 Participants
Region of Enrollment
Israel
46 participants
n=5 Participants
45 participants
n=7 Participants
91 participants
n=5 Participants

PRIMARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Average of blood test results at -10 and 0 days (before and after run-in period)

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
LDL Cholesterol
159.7 mg/dl
Standard Deviation 17.22
157.8 mg/dl
Standard Deviation 15.54

PRIMARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
LDL-C
154.7 md/dl
Standard Deviation 21.0
155.1 md/dl
Standard Deviation 20.1

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Average of blood test results at -10 and 0 weeks (before and after run-in period)

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Triglycerides
244.9 mg/dl
Standard Deviation 83.2
248.9 mg/dl
Standard Deviation 65.4

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Triglycerides
193.9 mg/dl
Standard Deviation 77.0
233.0 mg/dl
Standard Deviation 95.0

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Average of blood test results at -10 and 0 weeks (before and after run-in period)

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Total Cholesterol
244.3 mg/dl
Standard Deviation 24.7
239.6 mg/dl
Standard Deviation 22.7

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Total Cholesterol
233.8 mg/dl
Standard Deviation 28.0
236.5 mg/dl
Standard Deviation 27.7

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Average of blood test results at -10 and 0 weeks (before and after run-in period)

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
HDL Cholesterol
46.0 mg/dl
Standard Deviation 9.1
44.2 mg/dl
Standard Deviation 7.7

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
HDL-cholestrol
46.4 mg/dl
Standard Deviation 9.8
44.7 mg/dl
Standard Deviation 10.5

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results on day 0 of High sensitivity C Reactive Protein

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
CRP
3.07 mg/l
Standard Deviation 3.45
3.25 mg/l
Standard Deviation 2.61

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention of High sensetivity C reactive protein

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
CRP
2.47 mg/l
Standard Deviation 2.45
4.51 mg/l
Standard Deviation 4.15

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results on day 0

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Apolipoprotein B100
130.6 mg/dl
Standard Deviation 15.7
129.4 mg/dl
Standard Deviation 14.3

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results follwing 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Apolipoprotein B100
130.0 mg/dl
Standard Deviation 19.1
130.3 mg/dl
Standard Deviation 17.0

SECONDARY outcome

Timeframe: at baseline

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test on day 0

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Apolipoprotein A
126.3 mg/dl
Standard Deviation 13.5
125.6 mg/dl
Standard Deviation 13.6

SECONDARY outcome

Timeframe: 12 weeks

Population: Subjects whose body weight were changed from baseline value by more than 3 kg during the interventions or had compliance below 65% were excluded from analysis before breaking the randomization code. It was done since these changes may have a significant influence on the study end points

Blood test results following 12 weeks of intervention

Outcome measures

Outcome measures
Measure
PS-FO
n=34 Participants
plant sterols esterified to fish oil fatty acids
Control
n=33 Participants
Corn oil
Apolipoprotein A
128.2 mg/dl
Standard Deviation 14.5
127.8 mg/dl
Standard Deviation 16.3

Adverse Events

PS-FO

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
PS-FO
n=46 participants at risk
plant sterols esterified to fish oil fatty acids
Control
n=45 participants at risk
Corn oil
Gastrointestinal disorders
abdominal discomfort
0.00%
0/46
2.2%
1/45 • Number of events 1
Skin and subcutaneous tissue disorders
Itching rash
2.2%
1/46 • Number of events 1
0.00%
0/45

Additional Information

Prof. Dror Harats

The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer

Phone: 972-3-5302940

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place